WASHINGTON — The Biden administration on Friday said it will not lower Medicare premiums for adults 65 and over this year, even though their costs spiked based on inflated financial projections for the beleaguered Alzheimer’s drug, Aduhelm.
Health and Human Services Secretary Xavier Becerra in January publicly announced he was ordering Medicare to consider dropping older adults’ premiums in the middle of this year, which would have been an unprecedented move. But the administration decided against a change due to “legal and operational hurdles,” the department said Friday afternoon.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
